Treatment | Baseline (M ± SD) | Week 25 (M ± SD) | Mean change (M ± SD) | % Change (± SD) | 95% CI | Cohen’s d |
---|---|---|---|---|---|---|
All | 0.319 ± 0.034 | 0.333 ± 0.043 | 0.016 ± 0.030 | 5.35 | 2.07, 8.55 | – |
First-stage interventions | Â | Â | Â | Â | Â | Â |
 NC | 0.324 ± 0.041 | 0.339 ± 0.042 | 0.018 ± 0.024 | 6.04 ± 7.81 | – | – |
 EC | 0.314 ± 0.027 | 0.327 ± 0.044 | 0.014 ± 0.035 | 4.63 ± 11.08 | – | – |
Between-group difference | – | – | – |  − 1.41 |  − 8.18, 5.36 |  − 0.27 |
Response to first-stage interventions | Â | Â | Â | Â | Â | Â |
 All responders | 0.308 ± 0.026 | 0.344 ± 0.044 | 0.035 ± 0.032 | 11.52 ± 9.99 | 6.30, 17.29 | – |
 NC Responder | 0.311 ± 0.031 | 0.336 ± 0.037 | 0.026 ± 0.028 | 8.59 ± 9.25 | – | – |
 EC Responder | 0.306 ± 0.022 | 0.353 ± 0.054 | 0.047 ± 0.357 | 14.94 ± 10.53 | – | – |
Between-group difference | – | – | – | 6.35 |  − 5.71, 18.42 |  − 0.17 |
Second-stage interventions | Â | Â | Â | Â | Â | Â |
 All non-responders | 0.323 ± 0.039 | 0.326 ± 0.041 | 0.003 ± 0.021 | 1.34 ± 6.57 | 4.57, 7.83 | – |
 WLC | 0.320 ± 0.034 | 0.333 ± 0.029 | 0.010 ± 0.024 | 3.67 ± 7.61 | – | – |
 Metformin | 0.325 ± 0.046 | 0.319 ± 0.051 |  − 0.002 ± 0.014 |  − 0.97 ± 4.61 | – | – |
Between-group difference | – | – | – | 4.63 |  − 1.27, 10.55 | 0.73 |